floxuridine has been researched along with African Lymphoma in 1 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, TC | 1 |
| Milner, AE | 1 |
| Gregory, CD | 1 |
| Jackman, AL | 1 |
| Aherne, GW | 1 |
| Hartley, JA | 1 |
| Dive, C | 1 |
| Hickman, JA | 1 |
1 other study available for floxuridine and African Lymphoma
| Article | Year |
|---|---|
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
Topics: Apoptosis; Burkitt Lymphoma; DNA Damage; DNA, Neoplasm; Drug Resistance; Floxuridine; Folic Acid; Hu | 1993 |